Jobs at Summit Therapeutics, Inc.

Lead regional commercialization and launch of an oncology therapy by recruiting, coaching, and managing a high-performing field sales team; execute sales strategies, partner cross-functionally, monitor KPIs, provide market insights, and ensure compliant commercial activities while traveling frequently.

Lead strategic account engagement to secure market access for oncology medicines across IDNs, academic centers, regional health systems, and community networks. Build C-suite and multi-level relationships, negotiate contracts, align cross-functional teams, drive pathway and formulary inclusion, provide market insights, and support product launch and long-term partnership strategies. Travel up to 50% and conduct quarterly business reviews.

Leads global compensation and benefits programs, including salary structures, incentive plans, equity, benefits, open enrollment, 401(k), leave administration, compliance, audits, and payroll coordination. Owns HR metrics, systems, policies, process improvements, change management, and AI-in-HR strategy. Partners with leadership, vendors, payroll, IT, and external stakeholders to improve employee experience and operational efficiency.

The Director, Value Outcomes Liaison engages payers, health systems, P&T committees, pathway organizations, and policymakers to communicate clinical, humanistic, and economic evidence for ivonescimab. The role develops stakeholder relationships, supports formulary and pathway inclusion, collaborates with HEOR, medical affairs, and market access teams, communicates evidence gaps, and informs engagement strategies. Extensive healthcare and pharmaceutical experience, oncology knowledge, field-based market access expertise, and frequent travel are required.

Leads value-outcomes engagement with U.S. payers, health systems, pathway organizations, P&T committees, and policymakers. Provides objective clinical, economic, and humanistic information on ivonescimab; supports formulary, pathway, and treatment-order-set decisions; collaborates with medical affairs, HEOR, and market access teams; develops stakeholder relationships, communicates evidence, identifies evidence gaps, and informs access strategy. Requires extensive healthcare and pharmaceutical experience, oncology knowledge, field-based market access expertise, and up to 75% travel.

Owns Summit’s federal account strategy for VA, VHA, DoD, DHA, and TRICARE systems ahead of oncology portfolio launch. Responsibilities include federal contracting readiness, FSS contract and pricing management, formulary and pathway access, account planning, stakeholder relationship development, reimbursement navigation, evidence coordination, and compliance with federal pharmaceutical regulations. The role is a senior individual contributor expected to build and lead the federal function as the portfolio expands.

Lead global regulatory strategy for oncology programs from IND/CTA through BLA/MAA and post‑marketing. Provide cross‑functional regulatory leadership, lead due diligence for partnerships, mentor RA staff, drive labeling and risk‑mitigation strategy, liaise with global authorities, and support product launch activities with minimal oversight.

Lead global regulatory strategy and execution for oncology products, securing IND/CTA approvals and supporting BLA/MAA submissions. Provide regulatory leadership across regions, advise cross-functional teams on regulatory requirements, mentor RA staff, manage labeling activities, and interface with major regulatory authorities to ensure program success.

The Sr. Commercial Attorney will support the launch of Ivonescimab by drafting and negotiating commercial agreements, ensuring compliance with regulations, and advising on market strategies.